| Pharmaceutical active ingredients: |
| Meglumine Sodium Succinate |
| Available forms, composition and doses of Reambisar: |
| Injectable; Injection; Meglumine Sodium Succinate 15 mg / ml |
| Reambisar medical category: |
| Human:Contrast mediumsRoentgenography |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B05AA - Blood substitutes and plasma protein fractions |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Biohimik |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Telebrix Coronario | Meglumine Ioxitalamate; Sodium Ioxitalamate | Guerbet; Temis Lostalo Laboratorios |
| Telebrix N | Meglumine Ioxitalamate; Sodium Ioxitalamate | Guerbet; X Pharma |
| Telebrix N 350 | Meglumine Ioxitalamate; Sodium Ioxitalamate | Guerbet; Altana Pharma; Zentiva |
| Telebrix N 380 | Meglumine Ioxitalamate; Sodium Ioxitalamate | Guerbet; Altana Pharma; Zentiva |
| Reamberin | Meglumine Sodium Succinate | Polysan |
| Lipoglutaren | Meglutol | Recordati |
| Mevalon | Meglutol | Guidotti Laboratori |
| Poconeol N 71 | Meibomia Triflora; Scandix Cerofolium; Solanum Nigrum | Plantes et Medecines Laboratoires |
| Lisidonil | Meladrazine | Unidentified Pharmaceutical Company |
| Exanta | Melagatran; Ximelagatran | AstraZeneca |